Longer-term tofacitinib effectiveness for the treatment of ulcerative colitis: Two-year outcomes from a UK observational cohort study

被引:0
|
作者
Honap, S. [1 ,2 ]
Sharma, E. [1 ]
Ray, S. [1 ]
Mawdsley, J. [1 ]
Anderson, S. [1 ]
Samaan, M. [1 ]
Pavlidis, P. [1 ,2 ]
Irving, P. [1 ,2 ]
机构
[1] Guys & St Thomas NHS Fdn Trust, IBD Ctr, Dept Gastroenterol, London, England
[2] Kings Coll London, Sch Immunol & Microbial Sci, London, England
来源
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P430
引用
收藏
页码:I414 / I415
页数:2
相关论文
共 50 条
  • [1] LONGER-TERM TOFACITINIB EFFECTIVENESS FOR THE TREATMENT OF ULCERATIVE COLITIS: TWO-YEAR OUTCOMES FROM A UK OBSERVATIONAL COHORT STUDY
    Honap, Sailish
    Sharma, Esha
    Ray, Shuyra
    Mawdsley, Joel
    Anderson, Simon H.
    Samaan, Mark A.
    Pavlidis, Polychronis
    Irving, Peter M.
    GASTROENTEROLOGY, 2022, 162 (07) : S988 - S989
  • [2] Longer-term tofacitinib effectiveness for the treatment of ulcerative colitis: Two-year outcomes from a UK observational cohort study
    Honap, S.
    Sharma, E.
    Ray, S.
    Mawdsley, J.
    Anderson, S.
    Samaan, M.
    Pavlidis, P.
    Irving, P.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I414 - I415
  • [3] SAFETY ANALYSIS OF TOFACITINIB IN ULCERATIVE COLITIS: REALWORLD OUTCOMES FROM A THREE-YEAR UK OBSERVATIONAL COHORT STUDY
    Honap, Sailish
    Sharma, Esha
    Ray, Shurva
    Mawdsley, Joel
    Anderson, Simon H.
    Samaan, Mark A.
    Pavlidis, Rolychronis
    Irving, Peter M.
    GASTROENTEROLOGY, 2022, 162 (07) : S989 - S989
  • [4] Safety analysis of tofacitinib in ulcerative colitis: Real-world outcomes from a three-year UK observational cohort study
    Honap, S.
    Sharma, E.
    Ray, S.
    Mawdsley, J.
    Anderson, S.
    Samaan, M.
    Pavlidis, P.
    Irving, P.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I510 - I510
  • [5] Safety analysis of tofacitinib in ulcerative colitis: Real-world outcomes from a three-year UK observational cohort study
    Honap, S.
    Sharma, E.
    Ray, S.
    Mawdsley, J.
    Anderson, S.
    Samaan, M.
    Pavlidis, P.
    Irving, P.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I510 - I510
  • [6] Effectiveness and safety of tofacitinib for ulcerative colitis: two-year results of the ICC Registry
    Straatmijer, Tessa
    van Schaik, Fiona D. M.
    Bodelier, Alexander G. L.
    Visschedijk, Marijn
    de Vries, Annemarie C.
    Ponsioen, Cyriel Y.
    Pierik, Marieke
    van Bodegraven, Ad A.
    West, Rachel L.
    de Boer, Nanne K. H.
    Srivastava, Nidhi
    Romkens, Tessa E. H.
    Hoekstra, Jildou
    Oldenburg, Bas
    Dijkstra, Gerard
    van der Woude, Janneke C.
    Lowenberg, Mark
    Mujagic, Zlatan
    Biemans, Vince B. C.
    Van der Meulen-de Jong, Andrea E.
    Duijvestein, Marjolijn
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 57 (01) : 117 - 126
  • [7] Tofacitinib for ulcerative colitis in Brazil: a multicenter observational study on effectiveness and safety
    Parra, Rogerio Serafim
    Froes, Renata de Sa Brito
    Magro, Daniela Oliveira
    da Costa Ferreira, Sandro
    de Mello, Munique Kurtz
    de Azevedo, Matheus Freitas Cardoso
    Damiao, Aderson Omar Mourao Cintra
    de Sousa Carlos, Alexandre
    Barros, Luisa Leite
    de Miranda, Maria Luiza Queiroz
    Vieira, Andrea
    Sales, Marcos Paulo Moraes
    Zabot, Gilmara Pandolfo
    Cassol, Ornella Sari
    Alves Jr, Antonio Jose Tiburcio
    Lubini, Marcio
    Machado, Marta Brenner
    Flores, Cristina
    Teixeira, Fabio Vieira
    Coy, Claudio Saddy Rodrigues
    Zaltman, Cyrla
    Chebli, Liliana Andrade
    Sassaki, Ligia Yukie
    Feres, Omar
    Chebli, Julio Maria Fonseca
    BMC GASTROENTEROLOGY, 2025, 25 (01)
  • [8] Effectiveness and Safety of Tofacitinib in the Management of Ulcerative Colitis: A Brazilian Observational Multicentric Study
    Perin, Ramir Luan
    Magro, Daniela Oliveira
    Andrade, Adriana Ribas
    Argollo, Marjorie
    Carvalho, Nayara Salgado
    Damiao, Aderson Omar Moura Cintra
    Dotti, Adriana Zanoni
    Ferreira, Sandro da Costa
    Flores, Cristina
    Ludvig, Juliano Coelho
    Nones, Rodrigo Bremer
    Queiroz, Natalia Sousa Freitas
    Parra, Rogerio Serafim
    Steinwurz, Flavio
    Teixeira, Fabio Vieira
    Kotze, Paulo Gustavo
    CROHNS & COLITIS 360, 2023, 5 (01)
  • [9] Effectiveness and Safety of Tofacitinib in the Management of Ulcerative Colitis: A Brazilian Observational Multicentric Study
    Parra, Rogerio S.
    Froes, Renata de Sa Brito
    Magro, Daniela Oliveira
    Ferreira, Sandro da Costa
    de Mello, Munique Kurtz
    de Azevedo, Matheus Freitas Cardoso
    Damiao, Aderson Omar Mourao Cintra
    Carlos, Alexandre de Sousa
    Barros, Luisa Leite
    de Miranda, Maria Luiza Queiroz
    Vieira, Andrea
    Moraes Sales, Marcos Paulo
    Gabot, Gilmara
    Cassol, Ornella Sari
    Alves Junior, Antonio Jose Tiburcio
    Lubini, Marcio
    Machado, Marta Brenner
    Flores, Cristina
    Teixeira, Fabio Vieira
    Coy, Claudio Saddy Rodrigues
    Sassaki, Ligia Yukie
    Feres, Omar
    Chebli, Julio Maria Fonseca
    Zaltman, Cyrla
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (12S): : S25 - S25
  • [10] ONE-YEAR COMPARATIVE EFFECTIVENESS OF UPADACITINIB VERSUS TOFACITINIB FOR ULCERATIVE COLITIS: A MULTICENTER COHORT STUDY
    Dalal, Rahul S.
    Kallumkal, Govind
    Cabral, Heidy
    Barnes, Edward L.
    Allegretti, Jessica R.
    GASTROENTEROLOGY, 2024, 166 (05) : S56 - S57